Abstract
Individuals with schizophrenia (SCZ) have high rates of cannabis and tobacco co-use but the relationships between these substances in SCZ is unknown. In a previous study on cannabis use disorder in schizophrenia versus non-psychiatric controls, we found that 28-days of cannabis abstinence was associated with selective improvements in cognitive function (e.g. verbal and memory) and increased compensatory tobacco use compared to controls. Here, we further explored cannabis and tobacco co-use in SCZ participants undergoing repetitive transcranial magnetic stimulation (rTMS) as a method for reducing cannabis use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
